Edgen Stock·Oct 04 2025, 21:22戻る
戻る
Veru Inc. Secures FDA Regulatory Clarity for Enobosarm in Obesity Treatment
Edgen Stock·Oct 04 2025, 21:22
[1] Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity[2] Veru receives FDA guidance for obesity drug enobosarm - Investing.com[3] Veru receives FDA guidance for obesity drug enobosarm - Investing.com UK